SpringWorks Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
NEW YORK--(BUSINESS WIRE)--SpringWorks Therapeutics, a mission-driven medicines company dedicated to developing innovative potential new treatments for underserved patient communities, today announced that it will present at the 36thAnnual J.P. Morgan Healthcare Conference. Lara S. Sullivan, M.D., President and Founder, and Saqib Islam, Chief Financial Officer and Chief Business Officer, are scheduled to present at 1:30 p.m. PT on Tuesday, January 9, 2018 at the Westin St. Francis in San Francisco, CA.
“Having launched SpringWorks Therapeutics only four months ago, we are honored to have been selected to present at the J.P. Morgan Healthcare Conference,” stated Mr. Islam. “Our collaborative, patient-centric business model is providing innovative ways to advance promising, investigational therapies that may be otherwise trapped on the sidelines in larger pharmaceutical and biotech companies. We look forward to sharing highlights of our novel approach and late-stage pipeline as we enter a catalyst-rich 2018.”
About SpringWorks Therapeutics
SpringWorks Therapeutics is a mission-driven medicines company dedicated to developing innovative potential new treatments for underserved patient communities. The company’s collaborative business model is designed to deliver both social and financial returns via partnerships with a variety of stakeholders, including patients, families, foundations, scientists, academia, biopharmaceutical partners, funders and philanthropists. For more information, please visit www.springworkstx.com.
Contacts
W2Opure
Investor Contact:
Courtney Dugan, 212-257-6723
cdugan@w2ogroup.com
or
Media Contact:
Katie Engleman, 910-509-3977
kengleman@w2ogroup.com